✨ Consent to Distribution of New Medicines
3958
THE NEW ZEALAND GAZETTE
No. 145
Consent to the Distribution of New Medicines
PURSUANT to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
SCHEDULE
| Name and Strength | Form | Name and Address of Manufacturer | Proprietary Name (if any) |
|---|---|---|---|
| Diazoxide BP 300 mg in 20 ml | Injection (ampoule) | David Bull Laboratories Pty Ltd., Australia | — |
| Lidocaine 2.5% w/w) | Cream | Astra Pharmaceuticals, Sweden | Emla |
| Prilocaine 2.5% w/w) | Powder for injection (vials) | Pharmachemie BV, Holland | Platosin |
| Cisplatin 10 mg, 25 mg and 50 mg | Solution for injection | Pharmachemie BV, Holland | Platosin |
| Cisplatin 0.5 mg per ml | Tablet | Marion Laboratories Inc., U.S.A. | GVC and GVC 2 |
| Algic acid 200 mg & 400 mg) | Oral suspension | Marion Laboratories Inc., U.S.A. | GVC Liquid |
| Aluminium hydroxide 80 mg & 160 mg) | |||
| Sodium bicarbonate 70 mg & 140 mg) | |||
| Magnesium trisilicate 20 mg & 40 mg) | |||
| Aluminium hydroxide and Magnesium carbonate complex 0.9% w/v) | |||
| Magnesium carbonate 2.4% w/v) | |||
| Sodium alginate 2.5% w/v) |
Dated this 6th day of September 1986.
MICHAEL BASSETT, Minister of Health.
25
Consent to the Distribution of New Medicines
PURSUANT to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
SCHEDULE
| Name and Strength | Form | Name and Address of Manufacturer | Proprietary Name (if any) |
|---|---|---|---|
| Baclofen USP 10 mg and 25 mg | Tablet | Alphapharm Pty Ltd., Australia | Pacifen “10” and “25” |
| Tubocurarine chloride BP 1% w/v | Injection | David Bull Laboratories Pty. Ltd., Australia | — |
| Amitriptyline HCl BP 10 mg, 25 mg and 50 mg | Tablet | Glaxo Ltd., New Zealand | — |
| Silver sulphadiazine 1% w/w | Cream | Marion Laboratories Inc., U.S.A. | Silvadene |
| Sulphur 3% w/w | Cream | Shiseido Ltd., Japan | Shiseido Pureness Spot Cream |
| Quinine sulphate 200 mg and 300 mg | Tablet | Tablet Manufacturers Ltd., New Zealand | — |
| Hydroxyapatite compound 830 mg | Tablet | Labas: Sanofi Ltd., England | Ossopan 800 |
Dated this 6th day of September 1986.
MICHAEL BASSETT, Minister of Health.
30
Next Page →
PDF embedding disabled (Crown copyright)
View this page online at:
VUW Te Waharoa —
NZ Gazette 1986, No 145
NZLII —
NZ Gazette 1986, No 145
✨ LLM interpretation of page content
🏥 Consent to Distribution of New Medicines
🏥 Health & Social Welfare6 September 1986
Medicines, Distribution, Consent, Medicines Act 1981
- Michael Bassett, Minister of Health
🏥 Consent to Distribution of New Medicines
🏥 Health & Social Welfare6 September 1986
Medicines, Distribution, Consent, Medicines Act 1981
- Michael Bassett, Minister of Health